⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers

Official Title: DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers

Study ID: NCT04165564

Study Description

Brief Summary: DECAMP 1 PLUS aims to improve the efficiency of the diagnostic evaluation of patients with indeterminate pulmonary nodules (8-25 mm). Molecular biomarkers for lung cancer diagnosis measured in minimally invasive and non-invasive biospecimens may be able to distinguish between malignant or benign indeterminate pulmonary nodules in high-risk smokers. Ultimately, this study aims to validate molecular as well as clinical and imaging biomarkers of lung cancer in individuals with indeterminate lung nodules.

Detailed Description: The Detection of Early lung Cancer Among Military Personnel (DECAMP) consortium is a multidisciplinary and translational research program that previously initiated the DECAMP-1 and DECAMP-2 studies for lung cancer early detection. Now, with the support of Johnson and Johnson, 3 Veterans Administration Hospitals (VAH), 3 Military Treatment Facilities (MTF) and 12 academic hospitals as clinical study sites, several molecular biomarker laboratories, along with Biostatics, Bioinformatics, Pathology and Biorepository cores, we are expanding our work in lung cancer early detection.

Eligibility

Minimum Age: 46 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

University of Alabama, Birmingham, Birmingham, Alabama, United States

University of California Los Angeles, Los Angeles, California, United States

VA Greater LA Healthcare System, Los Angeles, California, United States

Naval Medical Center San Diego, San Diego, California, United States

University of Iowa, Iowa City, Iowa, United States

Walter Reed Army Medical Center, Bethesda, Maryland, United States

VA Boston Healthcare System, Boston, Massachusetts, United States

University of Michigan, Ann Arbor, Michigan, United States

Mayo Clinic, Rochester, Minnesota, United States

Cleveland Clinic, Cleveland, Ohio, United States

American College of Radiology [Administrative Site], Philadelphia, Pennsylvania, United States

University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States

Temple University, Philadelphia, Pennsylvania, United States

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

Brown University [Administrative Site], Providence, Rhode Island, United States

VA Tennessee Valley Healthcare System, Nashville, Tennessee, United States

MD Anderson Cancer Center [Administrative Site], Houston, Texas, United States

Naval Medical Center Portsmouth, Portsmouth, Virginia, United States

West Virginia University, Morgantown, West Virginia, United States

Contact Details

Name: Ehab Billatos, MD

Affiliation: Boston University

Role: PRINCIPAL_INVESTIGATOR

Name: Denise Aberle, MD

Affiliation: University of California, Los Angeles

Role: PRINCIPAL_INVESTIGATOR

Name: George Washko, MD

Affiliation: Brigham and Women's Hospital

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: